Brentuximab vedotin: Powder for I.V. infusion 50 mg; Adcetris® Page last updated: 2 July 2021 Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1985KB) Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 2984KB)